rs35662416

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_030787.4(CFHR5):​c.1067G>A​(p.Arg356His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0237 in 1,609,466 control chromosomes in the GnomAD database, including 548 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R356C) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.017 ( 29 hom., cov: 32)
Exomes 𝑓: 0.024 ( 519 hom. )

Consequence

CFHR5
NM_030787.4 missense

Scores

1
16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: -2.28

Publications

23 publications found
Variant links:
Genes affected
CFHR5 (HGNC:24668): (complement factor H related 5) This gene is a member of a small complement factor H (CFH) gene cluster on chromosome 1. Each member of this gene family contains multiple short consensus repeats (SCRs) typical of regulators of complement activation. The protein encoded by this gene has nine SCRs with the first two repeats having heparin binding properties, a region within repeats 5-7 having heparin binding and C reactive protein binding properties, and the C-terminal repeats being similar to a complement component 3 b (C3b) binding domain. This protein co-localizes with C3, binds C3b in a dose-dependent manner, and is recruited to tissues damaged by C-reactive protein. Allelic variations in this gene have been associated, but not causally linked, with two different forms of kidney disease: membranoproliferative glomerulonephritis type II (MPGNII) and hemolytic uraemic syndrome (HUS). [provided by RefSeq, Jan 2010]
CFHR5 Gene-Disease associations (from GenCC):
  • C3 glomerulonephritis
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009272099).
BP6
Variant 1-196998224-G-A is Benign according to our data. Variant chr1-196998224-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 402533.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0171 (2602/152062) while in subpopulation NFE AF = 0.0261 (1773/67952). AF 95% confidence interval is 0.0251. There are 29 homozygotes in GnomAd4. There are 1180 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 2602 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_030787.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CFHR5
NM_030787.4
MANE Select
c.1067G>Ap.Arg356His
missense
Exon 7 of 10NP_110414.1Q9BXR6

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CFHR5
ENST00000256785.5
TSL:1 MANE Select
c.1067G>Ap.Arg356His
missense
Exon 7 of 10ENSP00000256785.4Q9BXR6
CFHR5
ENST00000699466.1
c.812G>Ap.Arg271His
missense
Exon 7 of 10ENSP00000514393.1A0A8V8TNA3
CFHR5
ENST00000699468.1
c.161G>Ap.Arg54His
missense
Exon 3 of 6ENSP00000514394.1A0A8V8TNF4

Frequencies

GnomAD3 genomes
AF:
0.0171
AC:
2603
AN:
151944
Hom.:
29
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00547
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.0250
Gnomad ASJ
AF:
0.00404
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00497
Gnomad FIN
AF:
0.0121
Gnomad MID
AF:
0.0222
Gnomad NFE
AF:
0.0261
Gnomad OTH
AF:
0.0230
GnomAD2 exomes
AF:
0.0163
AC:
4073
AN:
249494
AF XY:
0.0165
show subpopulations
Gnomad AFR exome
AF:
0.00522
Gnomad AMR exome
AF:
0.0191
Gnomad ASJ exome
AF:
0.00568
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0130
Gnomad NFE exome
AF:
0.0246
Gnomad OTH exome
AF:
0.0228
GnomAD4 exome
AF:
0.0244
AC:
35503
AN:
1457404
Hom.:
519
Cov.:
30
AF XY:
0.0238
AC XY:
17233
AN XY:
725058
show subpopulations
African (AFR)
AF:
0.00405
AC:
135
AN:
33362
American (AMR)
AF:
0.0192
AC:
856
AN:
44520
Ashkenazi Jewish (ASJ)
AF:
0.00484
AC:
126
AN:
26042
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39502
South Asian (SAS)
AF:
0.00340
AC:
291
AN:
85594
European-Finnish (FIN)
AF:
0.0150
AC:
800
AN:
53218
Middle Eastern (MID)
AF:
0.0106
AC:
61
AN:
5746
European-Non Finnish (NFE)
AF:
0.0286
AC:
31761
AN:
1109284
Other (OTH)
AF:
0.0245
AC:
1473
AN:
60136
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
1534
3069
4603
6138
7672
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1200
2400
3600
4800
6000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0171
AC:
2602
AN:
152062
Hom.:
29
Cov.:
32
AF XY:
0.0159
AC XY:
1180
AN XY:
74344
show subpopulations
African (AFR)
AF:
0.00545
AC:
226
AN:
41470
American (AMR)
AF:
0.0250
AC:
381
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.00404
AC:
14
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00498
AC:
24
AN:
4824
European-Finnish (FIN)
AF:
0.0121
AC:
128
AN:
10586
Middle Eastern (MID)
AF:
0.0238
AC:
7
AN:
294
European-Non Finnish (NFE)
AF:
0.0261
AC:
1773
AN:
67952
Other (OTH)
AF:
0.0228
AC:
48
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
128
256
384
512
640
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0223
Hom.:
77
Bravo
AF:
0.0175
TwinsUK
AF:
0.0291
AC:
108
ALSPAC
AF:
0.0226
AC:
87
ESP6500AA
AF:
0.00681
AC:
30
ESP6500EA
AF:
0.0282
AC:
242
ExAC
AF:
0.0158
AC:
1924
Asia WGS
AF:
0.00405
AC:
14
AN:
3472

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
6
not provided (6)
-
-
2
not specified (2)
-
-
1
Atypical hemolytic-uremic syndrome (1)
-
-
1
CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II (1)
-
-
1
CFHR5 deficiency (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.095
BayesDel_addAF
Benign
-0.64
T
BayesDel_noAF
Benign
-0.67
CADD
Benign
4.3
DANN
Uncertain
0.98
DEOGEN2
Benign
0.0029
T
Eigen
Benign
-1.0
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.0032
N
LIST_S2
Benign
0.75
T
MetaRNN
Benign
0.0093
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.8
L
PhyloP100
-2.3
PrimateAI
Benign
0.31
T
PROVEAN
Benign
-0.33
N
REVEL
Benign
0.13
Sift
Benign
0.17
T
Sift4G
Benign
0.14
T
Polyphen
0.82
P
Vest4
0.051
MPC
0.023
ClinPred
0.024
T
GERP RS
-6.6
Varity_R
0.022
gMVP
0.54
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35662416; hg19: chr1-196967354; COSMIC: COSV99890169; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.